Tylent at the VZA Annual Conference of Cytostatic Compounding Pharmacies

Tylent Technologies will participate in the Annual Conference of Cytostatic Compounding Pharmacies

VZA Jahrestagung der Zytostatika herstellenden Apotheken

March 20–21, 2025
Meliá Hotel, Berlin

The event brings together German pharmacies specialised in cytostatic preparation and IV compounding to discuss the operational, clinical and technological challenges shaping the future of oncology pharmacy services.

During the conference, Gaspar G. De Viedma will be available at the Tylent Technologies booth to present the vision and technology behind Lyvra™ — a new automation architecture designed to rethink i.v. compounding workflows from the ground up.

While no physical demonstrator will be present at this event, visitors will be able to explore the Lyvra™ technology platform through presentations and multimedia materials, illustrating how AI-driven workflow orchestration, magnetic levitation material handling, and process-first automation may transform i.v. compounding productivity and scalability.

We look forward to meeting pharmacists and industry professionals from across Germany’s cytostatic compounding community and discussing how new technologies may help address the growing challenges of safety, workforce shortages, and increasing demand for patient-specific i.v. therapies.

More information about the event:
www.vza-info.de